Targeted therapy. Of your 175 sufferers (83 ) with EGFR(s) mutations, 146 had been treated
Targeted therapy. Of the 175 individuals (83 ) with EGFR(s) mutations, 146 were treated with targeted therapy: 130 with erlotinib alone, and 16 with another EGFR inhibitor alone or in…